Breast cancer circulating tumor cells with mesenchymal features-an unreachable target?

Cell Mol Life Sci · 2022 · PMC8770434 · PMID 35048186

Europe PMC DOI

hedged sentence

0.1300

closest p · 2.6× alpha

0.1300

boldest claim

The sentences

showed a trendp = 0.13not close (p > 0.1)

None of the markers showed difference in PRs between M0 and M1 patients, though VIM showed a trend towards higher PRs in M1 (59.5%) than in M0 group (20.5%, p = 0.13, Supplementary Table 4A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.